-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
- Inhibikase Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 7.46M shares, a 39.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)